题名

台灣藥價差亂象－醫療經濟學角度之分析及建議

并列篇名

Pharmaceutical market distortion under the current reimbursement policy-analyses and recommendations from a health economics’ perspective

DOI

10.6288/TJPH201635105017

作者

施廷芳(Sophy Ting-Fang Shih)；李禮君(Li-Chun Lee)；陳鴻儀(Hung-Yi Chen)

关键词
期刊名称

台灣公共衛生雜誌

卷期/出版年月

35卷2期（2016 / 04 / 01）

页次

113 - 115

内容语文

繁體中文
主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. 財團法人中華民國消費者文教基金會：「藥」或不「要」：讓原廠藥與學名藥回歸市場機制，政府應嚴格稽查學名藥之藥性。http://www.consumers.org.tw/unit412.aspx?id=1973。引用2016/03/28。Consumers's Foundation, Chinese Taipei. Yes or No to generic medicines: reinforcement of quality control for generic drugs to facilitate the market competition between originator and generic brands.Available at: http://www.consumers.org.tw/unit412.aspx?id=1973. Accessed March 28, 2016. [In Chinese]
  2. Department of Health, Australian Government. The pharmaceutical benefit schedule: brand premium policy. Available at: http://www.pbs.gov.au/browse/brand-premium. Accessed February 1, 2016
  3. Yang, HL,Shen, LJ,Huang, CF(2012).Are brand-name drugs of better quaility than generics? Research at a medical center in Taiwan.J Food Drug Anal Analysis,20,6-11.
print cancel